Skip to main content

Human Microbiome-based Products Market is projected to be worth USD 4 Billion by 2030, growing at an annualized rate of over 40%, claims Roots Analysis

 

Over the years, extensive R&D efforts have enabled microbiome-based therapy / diagnostic developers to make significant strides, in terms of progressing proprietary product candidates into the clinic

 

Roots Analysis has announced the addition of “Human Microbiome Market, 2019-2030” report to its list of offerings

 

To order this 640+ page report, which features 235+ figures and 275+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/human-microbiome-market/281.html

 

The report features an in-depth analysis, highlighting the diverse capabilities of stakeholders engaged in this domain. In addition to other elements, the study includes:

§  A detailed assessment of the current market landscape of microbiome therapeutics, providing information on drug / therapy developer(s).

§  Elaborate profiles of key players (established after 2005) that are engaged in the development of microbiome therapeutics.

§  A detailed review of the current market landscape of microbiome diagnostic tests, brief profiles of popular diagnostic developers and indicative list of screening and profiling test kits.

§  A detailed assessment of the current market landscape of FMT therapies, a geographical clinical trial analysis and information on various stool banks.

§  A detailed business portfolio analysis based on an attractiveness and competitiveness (AC) framework.

§  An analysis of the varied microbiome-focused initiatives of big pharma players.

§  An analysis of the start-ups / small-sized players engaged in the development of microbiome therapeutics and diagnostics.

§  An assessment of the most commonly targeted therapeutic indications and details of microbiome-based drugs.

§  An analysis of the investments made at various stages of development in start-ups / small-sized companies.

§  An indicative list of contract manufacturers, in-house manufacturers and CROs that currently claim to have the necessary capabilities.

§  An assessment of the emerging role of big data highlighting efforts focused on the development and implementation of various algorithms / tools to analyze data generated from in the microbiome research.

§  An informative case study on the various other applications of microbiome products, such as agriculture, animal health, plant health, food products

§  A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

segments:

§  Type of Therapy (Tx)

§  Prescription Drug

§  Prebiotics

§  Probiotics

       

§  Type of Molecule (Tx)

§  Small Molecules

§  Biologics

 

§  Target Indication (Tx+Dx)

§  Acne Vulgaris

§  Atopic Dermatitis

§  Clostridium difficile Infection

§  Colorectal Cancer

§  Crohn’s Disease

§  Diabetes

§  Irritable Bowel Syndrome

§  Lactose Intolerance

§  Lung Cancer

§  Nonalcoholic steatohepatitis (NASH)

§  Obesity

§  Ulcerative colitis

 

To request a sample copy / brochure of this report, please visit this- https://www.rootsanalysis.com/reports/281/request-sample.html

 

§  Therapeutic Area (Tx+Dx)

§  Autoimmune Disorders

§  Dental Disorders

§  Digestive and Gastrointestinal Disorders

§  Dermatological Disorders

§  Infectious Disease

§  Metabolic Disorders

§  Oncology

§  Others

 

§  Key Geographical Regions (Tx+Dx)

§  North America

§  Europe

§  Asia-Pacific and Rest of the World

 

Key companies covered in the report

§  4D Pharma

§  Armata Pharmaceuticals

§  Evelo Biosciences

§  Rebiotix (Acquired by Ferring Pharmaceuticals)

§  Seres Therapeutics

§  Vedanta Biosciences

 

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

 

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

ben.johnson@rootsanalysis.com

 

 

 

Labels:

Comments

Post a Comment

Popular posts from this blog

Manufacturing Market Continuous by Roots Analysis

    Recent advances in the manufacturing technologies have prompted pharmaceutical companies to consider shifting from the traditional multi-step, batch manufacturing processes to faster, and relatively more efficient continuous manufacturing   Roots Analysis is pleased to announce the publication of its recent study, titled, “ Manufacturing Market Continuous (Small Molecules and Biologics), 2020 – 2030 .”   The report features an extensive study of the current market landscape and future opportunities for companies with capabilities in continuous manufacturing (both innovator companies with in-house expertise and contract manufacturers). It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the study includes: §   A detailed assessment of the overall landscape of companies with capabilities for continuous manufacturing §   Elaborate profiles of some o...
Post a Comment
Read more

The Alzheimer’s disease market is anticipated to grow at an annualized rate of over 13%, till 2030, claims Roots Analysis

  Roots Analysis has announced the addition of “ Alzheimer's Disease Market (2 nd Edition), 2021-2031 ” report to its list of offerings.   Limited treatment options and unmet needs are the key drivers of research activity in this domain. Several industry and non-industry players are presently engaged in developing various types of disease modifying interventions and drug / therapy candidates that offer symptomatic relief. Moreover, multiple venture capital firms and other strategic investors have been supporting the research related initiatives of various start-ups. Driven by a rich development pipeline and the efforts of various stakeholders, the market is anticipated to grow at a significant pace in the coming future.   To order this 150+ page report, which features 90+ figures, please visit https://www.rootsanalysis.com/reports/view_document/alzheimers-disease-market/247.html   Key Market Insights   More than 240 drug candidates for the t...
Post a Comment
Read more

Continuous Manufacturing Market (Small Molecules and Biologics) by Roots Analysis

  To order this 310+ page report, which features 110+ figures and 200+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/continuous-manufacturing/308.html   Key Inclusions §   A detailed assessment of the overall landscape of companies with capabilities for continuous manufacturing, along with information on a number of relevant parameters, such as year of establishment, company size, purpose of manufacturing (in-house and contract services), scale of operation (preclinical, clinical and commercial), location of headquarters, location of manufacturing facilities, type of drug molecule (biologic and small molecule), type of continuous manufacturing related service(s) offered (process development, API manufacturing, intermediate manufacturing, drug product manufacturing, and packaging and fill / finish),   type of dosage form (solid and liquid), and installed capacity and batch size (if available). §   Elaborate profiles of so...
Post a Comment
Read more